JBAS Healthcare group round table organized
A round table with the topic Importance of medical innovations in improving healthcare – experiences of the Japanese business community, was held at the premises of the Embassy of Japan in Belgrade.
On Friday, 16th November 2018, a round table organized by Japanese Business Alliance in Serbia (JBAS), Embassy of Japan and Chamber of Commerce and Industry of Serbia (CCIS), with the topic Importance of medical innovations in improving healthcare – experiences of the Japanese business community, was held at the premises of the Embassy of Japan in Belgrade.
The event was opened by H.E. Mr. Junichi Maruyama, Ambassador of Japan in the Republic of Serbia, Prof. Ph.D. Vladimir Djukic, Deputy Minister of the Ministry of Health, Mr. Goran Pekez, President of JBAS and Director of JTI Corporate Affairs and Communications for the Western Balkans and Mrs. Mirjana Vucicevic, Head of Pharmaceutical and Medical Economy Association, CCIS.
Representatives of JBAS Healthcare group, Mr. Jovica Lukic, President of JBAS Healthcare Group and Country manager, Astellas Pharma d.o.o., Mrs. Milena Argirovic, Country Head Serbia/Bosnia and Herzegovina/Montenegro, Takeda GmbH, Representative Office Serbia, Mr. Dejan Tomovic, General Manager, Nipro Medical d.o.o. and Mr. Nenad Tiodorovic, TIS Market Development Manager Balkans, TERUMO EUROPE N.V have presented the activities and innovative solutions of their companies, while the participants, including the Director of Medicines and Medical Devices Agency of Serbia, Mr. Sasa Jacovic as well as the representatives of the National Health Insurance Fund, had the opportunity to hear more about the activities of JBAS Healthcare group and proposals for further cooperation enhancement.
The organization of the round table, was one of the first initiatives of the JBAS Healthcare group with a goal of establishing continued dialogue with the representatives of relevant healthcare institutions of the Republic of Serbia, exchanging experiences and providing support by Japanese companies through consideration of successful examples and practices of other countries where Japanese companies operate.
The round table itself considered the current state in the healthcare system of the Republic of Serbia, with a focus on the area of medicines and medical devices, where participants had the opportunity to hear mutual proposals for achieving a higher quality of health protection for citizens.